SEC
Fundamental Analysis
4 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNDMTANDEM DIABETES CARE INC | 47.6 | 100 | 100 | 91 | +3.96% | -17.91% | n/a | +7.19% | +2.92% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion1 warning |
| ANDEAndersons, Inc. | 45.8 | n/a | n/a | 79 | +22.86% | n/a | n/a | n/a | -0.13% | 1.18% | 31 | 28.05% | 19.71x | Share count reduction1 warning |
| SXISTANDEX INTERNATIONAL CORP/DE/ | 25.7 | n/a | n/a | 64 | -16.99% | n/a | n/a | n/a | n/a | 0.47% | 40 | n/a | n/a | Net debt reduction1 warning |
| CADLCandel Therapeutics, Inc. | 26.3 | 0 | 0 | 61 | 0% | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | n/a3 warnings |
1-4 of 4